Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease — Stella

Recruiting

Back to Alpha Thalassemia Hemoglobin H Constant Spring trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Nanning, Guangxi

Key details

Phase

Very early testing

Sponsor

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army

Collaborators

Guangzhou Reforgene Medicine Co., Ltd.

Enrollment target

~5 participants

Started

October 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years – 35 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov